论文部分内容阅读
目的:观察前列腺素E1治疗糖尿病足的疗效。方法:48例糖尿病足患者随机分成治疗组26例和对照组22例,治疗组给予前列腺素E1治疗。结果:治疗组治愈率、总有效率均明显高于对照组(P<0.05),平均好转天数、平均治愈天数均明显短于对照组(P<0.05)。结论:前列腺素E1是治疗糖尿病足安全有效的药物。
Objective: To observe the efficacy of prostaglandin E1 in the treatment of diabetic foot. Methods: Forty-eight patients with diabetic foot were randomly divided into treatment group (n = 26) and control group (n = 22). The treatment group was treated with prostaglandin E1. Results: The cure rate and total effective rate of the treatment group were significantly higher than those of the control group (P <0.05). The average days of improvement and the average number of days of cure were significantly shorter than those of the control group (P <0.05). Conclusion: Prostaglandin E1 is a safe and effective drug for the treatment of diabetic foot.